Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) has issued an announcement.
HeraMED Ltd. has applied to the ASX for quotation of 38,699,315 new fully paid ordinary shares under the ticker HMD. The securities form part of a transaction previously notified to the market, with the new shares issued on 2 April 2026.
The move will expand HeraMED’s quoted share base and may enhance liquidity for investors, while formalising the market listing of securities tied to earlier corporate activity. The application signals completion of a capital-related process that could support the company’s future funding and strategic options.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
YTD Price Performance: 38.89%
Average Trading Volume: 917,875
Technical Sentiment Signal: Buy
Current Market Cap: A$55.81M
For detailed information about HMD stock, go to TipRanks’ Stock Analysis page.